Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

77.15
+1.261.66%
Post-market: 77.190.0391+0.05%19:59 EDT
Volume:6.51M
Turnover:499.85M
Market Cap:342.47B
PE:24.56
High:77.55
Open:75.75
Low:75.24
Close:75.89
Loading ...

Diageo's Challenges Posed by GLP-1 Weight-Loss Drugs Cited by Fundsmith Manager for Selling Stake

MT Newswires Live
·
10 Jan

Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly

Dow Jones
·
10 Jan

NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to Buy

Zacks
·
09 Jan

Medicare Will Pay for Zepbound for Some Patients. The Costs Could be Huge -- Barrons.com

Dow Jones
·
09 Jan

LLY Falls Around 14% in 3 Months: How to Play the Stock

Zacks
·
09 Jan

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug

Zacks
·
09 Jan

Here's how Trump could impose tariffs on Denmark in a bid to control Greenland

Dow Jones
·
09 Jan

Donald Trump Wants Tariffs on Denmark Next. These Industries Would Be Hit Most. -- Barrons.com

Dow Jones
·
09 Jan

Novo Nordisk Received an Upgrade from UBS for Its Ozempic and Wegovy's Strong Brand Recognition

GuruFocus.com
·
09 Jan

Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'

Investopedia
·
09 Jan

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live
·
09 Jan

Top Calls on Wall Street: Nvidia, AMD, Netflix, Novo Nordisk, Adobe, Carvana & More

Tiger Newspress
·
08 Jan

Novo Nordisk Raised to Buy From Sell by UBS

Dow Jones
·
08 Jan

Novo Nordisk's CagriSema Selloff is Overdone, UBS Says -- Market Talk

Dow Jones
·
08 Jan

This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly

Motley Fool
·
08 Jan

Novo Nordisk, Valo Health Expand Collaboration to Include Obesity, Diabetes Programs

MT Newswires Live
·
08 Jan